Fundraising FoxBAM Elevate — 2026 Investments
9 investments dated 2026 · listed companies and verified rows first · show all
Relmada is a clinical-stage biopharmaceutical company developing therapies including NDV-01, a sustained-release intravesical formulation of gemcitabine and docetaxel for non-muscle invasive bladder cancer, and Sepranolone, a candidate targeting compulsive behaviors via GABAA receptor modulation.
BiotechHealthtechNew York, US
Sergio Traversa(Executive Officer, Director)Paul Kelly(Director)Maged Shenouda(Director)inEliseo O. Salinas(President and Chief Scientific Officer)inDouglas Beck(Chief Financial Officer)Charles Ence(Chief Accounting and Compliance Officer)
Co-investorsBioAdvanceBraidwellCommodore CapitalJanus Henderson InvestorsOrbiMedRA Capital+2 more
Sagimet is a clinical-stage biopharmaceutical company developing therapies targeting fatty acid synthase (FASN) for metabolic diseases and oncology.
BiotechDigital HealthHealthtechMenlo Park, US
Rekha Hemrajani(Executive Officer)inMerdad Parsey(Executive Officer, Director)inDavid Happel(Chief Executive Officer & Director)Andreas Grauer(Chief Medical Officer)inThierry Chauche(Chief Financial Officer)inMarie O'Farrell(Chief Scientific Officer)in
Co-investorsAltium CapitalHM Venture PartnersKleiner PerkinsNew Enterprise Associates (NEA)Biotechnology Value FundBlue Owl Capital+1 more
Applied Intuition develops physical AI software for autonomous and intelligent machines, including vehicles, robots, ships, and satellites across industries like automotive, defense, logistics, and manufacturing.
AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareRoboticsSunnyvale, US
Qasar Younis(Founder)inPeter Ludwig(Founder)inQasar Younis Peter Ludwig(Founder)
Co-investors137 VenturesAndreessen HorowitzBond Capital ManagementCatalytic Impact FoundationCoatue ManagementElad Gil+33 more
Astranis manufactures small, high-powered geosynchronous satellites equipped with advanced digital processing technology for global telecommunications and connectivity services.
Advanced ManufacturingDeep TechHardwareSpace TechSan Francisco, US
John Gedmark(CEO)inRyan McLinko(CTO)inMike Mancini(Executive Officer)Siamak Ebadi(Lead RF Engineer)inHall Chen(RF Payload Design)inShraddha Pandya(Talent Acquisition)
Co-investorsAndreessen HorowitzATEL VenturesBlack FlagBoxGroupCantos VenturesCherubic Ventures+87 more
Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.
AI & Machine LearningBiotech
Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)inMarie De Vulder(Chief Legal Officer Co-founder)inGuy Peeters(Chief Financial Officer Co-founder)inJohn-Paul Gallivan(Head of Development Co-founder)inFabrice Kolb(Head of Immunology Co-founder)inPieter Peeters(Operating & Technology Officer Co-founder)in
Co-investorsFinchley Healthcare VenturesLongwood FundLuma GroupSofinnova VenturesForbionNovo Holdings+2 more
Lycia Therapeutics is a biotechnology company developing LYTAC (Lysosomal Targeting Chimera) therapeutics that bind disease-causing extracellular and cell-surface proteins and route them into the cell's lysosome for degradation.
BiotechHealthtechSouth San Francisco, US
Carolyn Bertozzi(Lycia founder and Professor of Chemistry, Stanford University)inAetna Wun Trombley(President and CEO)inAmy Bachrodt(Chief Financial Officer)inChin Lee(Chief Medical Officer)inSteve Staben(Chief Scientific Officer)inSofia Touami(Chief Business Officer)in
Co-investorsREDMILEVersant VenturesHBM Healthcare InvestmentsHBM PartnersFranklin TempletonInvus+5 more
Saronic builds autonomous surface vessels — including the 180-foot, long-range Marauder — along with Echelon, a command-and-control software layer for planning, simulating and operating single vessels or fleets.
AI & Machine LearningDefense TechHardwareRoboticsAustin, US
Dino Mavrookas(Founder)inRob Lehman(Founder)inVibhav Altekar(Founder)inDoug Lambert(Founder)inPatrick DePriest(Chief Financial Officer)inSoo Cho(Chief People Officer)in
Co-investors1Flourish Capital8VCAdvent InternationalAlpha PartnersAndreessen HorowitzAnti+39 more
Skyryse develops SkyOS, a flight-control operating system that simplifies aircraft operation through automated maneuvers, emergency management, and optionally piloted or autonomous flight.
Deep TechDefense TechMobility & TransportationEl Segundo, US
Mark Groden(Founder)inStephen Koo(Executive Officer, Director)inBlake Bilstad(Executive Officer)in
BoardLior Susan(Director)inWill Summerlin(Director)Ethan Batraski(Director)in
Co-investorsCantos VenturesCity LightDas & Co.Embedded VenturesFlucas VenturesFOG Ventures+25 more
The Honest Company makes consumer personal care and baby products, including flushable wipes, marketed as clean-formula items that are toxicologist-audited, dermatologist-tested, cruelty-free, and made without synthetic fragrances.
ConsumerDirect to ConsumerE-commerceWellness & FitnessSanta Monica, US
Christopher Gavigan(Founder)Brian Lee(Founder)inSean Kane(Founder)inJessica Alba(Founder)inCraig Gatarz(Executive Officer)David Parker(Executive Officer)
Co-investorsFarvatn VentureGeneral CatalystICONIQIVP (Institutional Venture Partners)Lightspeed Venture PartnersMisfit Venture Partners+5 more
.png)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.